Navigation Links
ResMed Inc. Announces Record Financial Results For The Quarter Ended And Nine Months Ended March 31, 2013
Date:4/25/2013

nts receivable, net

293,489

283,160Inventories

166,483

174,351Prepayments, deferred income taxes and other current assets

107,205

94,099Total current assets

1,579,875

1,361,151Property, plant and equipment, net

444,495

434,363Goodwill

272,796

256,209Other intangibles

54,916

54,827Deferred income taxes and other non-current assets

22,874

31,319Total non-current assets

795,081

776,718Total assets

$2,374,956

$2,137,869Liabilities and Stockholders' EquityCurrent liabilities:Accounts payable

49,385

55,006Accrued expenses

127,850

127,381Deferred revenue

44,172

41,563Income taxes payable

18,330

27,777Deferred income taxes

632

1,073Current portion of long-term debt

340,052

52Total current liabilities

580,421

252,852Non-current liabilities:Deferred income taxes

9,262

8,843Deferred revenue

12,863

14,384Income taxes payable

3,486

3,380Non-current portion of long-term debt'/>"/>

SOURCE ResMed Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. ResMed Noninvasive Ventilation Device Cleared by FDA for COPD Treatment
2. ResMed Announces Conference Call And Webcast To Discuss Third Quarter 2013 Results
3. ResMed Takes Action to Enforce Patents
4. Buoyed by Forecasts, Where 2013 Leads - Research Report on ResMed Inc., Zimmer Holdings, Inc., Waters Corporation, Covidien PLC, and Medtronic, Inc.
5. ResMed Inc. Announces Record Financial Results For The Quarter Ended And Six Months Ended December 31, 2012
6. ResMed Inc. Announces Exchange Rate For Upcoming Dividend Payment
7. ResMed Inc. Announces Record Financial Results for the Quarter Ended September 30, 2012
8. ResMed Inc. Announces Record Financial Results For The Quarter And Twelve Months Ended June 30, 2012
9. ResMed Announces Conference Call And Webcast To Discuss Fourth Quarter And Fiscal Year-End 2012 Results
10. ResMed Launches Narval™ CC Mandibular Repositioning Device in the US
11. ResMed Inc. Announces Plan To Initiate Dividend And Update On Chief Executive Officer Succession
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 1, 2015 Jintian Pharmaceutical Group Limited ("Jintian ... Mr. Jin Dongtao, chairman and executive director purchased 40,000,000 ... of the existing entire issued share capital of the ... with the total amount of approximately HK$113 million. Upon ... will increase from 45.17% to 47.17%. ...
(Date:4/1/2015)... WALNUT CREEK, Calif. , April 1, 2015 /PRNewswire/ ... a huge difference.  When this is the case, having ... changer.  No one understands this truth better than software ... test laboratory management software QATrax.  Recently, the company announced ... a very enthusiastic response from clients. ...
(Date:4/1/2015)... , April 1, 2015  Egalet Corporation ... specialty pharmaceutical company focused on developing, manufacturing and ... of an offering of $60.0 million aggregate principal ... (the "notes") in a private placement to qualified ... Securities Act of 1933, as amended (the "Act"). ...
Breaking Medicine Technology:Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 2Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 3Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 4Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 5TraxStar Technologies Announces Latest QATrax Test Lab Management Software Now Available 2Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 2Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 3Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 4Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 5Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 6Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 7
... of its ongoing,efforts to develop research tools that ... disease, The Michael J. Fox,Foundation announced the launch ... the Foundation seeks to drive the creation,and testing ... with a personal,computer and an Internet connection to ...
... March 19 FluoroPharma Inc., a company,developing breakthrough ... (PET) market, announced commencement of Phase,I clinical trials ... the proposed studies. The Phase I trial is ... safety, distribution and dosimetry,of BFPET as a PET ...
Cached Medicine Technology:New Michael J. Fox Foundation Initiative Will Drive Development of Web-Based Tools to Increase Patient Participation in Parkinson's Clinical Trials 2FluoroPharma Announces Commencement of Phase I Clinical Trial for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2
(Date:4/1/2015)... The panel session will look at the need for ... program that can grow in a privacy-friendly manner, thus ... line. This topic has taken on even greater relevance ... dongles aren’t as secure as the automobile industry thought ... Progressive’s Snapshot dongles contained very significant security flaws, which ...
(Date:4/1/2015)... 01, 2015 Taking an important step ... League for Nursing Commission for Nursing Education Accreditation (NLN ... the first NLN CNEA Board of Commissioners. Working with ... the 15-member board will provide leadership and direction to ... accreditation decisions for nursing programs that seek accreditation from ...
(Date:4/1/2015)... Minn. (PRWEB) April 01, 2015 EAGAN, ... of Minnesota and its family of companies (Blue Cross) ... closed out the year with net income of $61.5 ... operational losses. The organization reported a net operating loss ... for a negative operating margin of one-tenth of one ...
(Date:4/1/2015)... CA (PRWEB) April 01, 2015 ... is announcing two continuing medical education (CME) courses ... to help practitioners become more confident in measuring, ... disease. After completion of these CME courses, practitioners ... , The CME courses available are “Vitamin D, ...
(Date:4/1/2015)... Aging2.0 , the global innovation ... launch of the Aging2.0 Alliance – a ... technology companies. The announcement was made today at the ... Strategies Forum in San Diego, CA. , ... is now open for additional members. “This is a ...
Breaking Medicine News(10 mins):Health News:TU-Automotive: Office of The Privacy Commissioner of Canada To Set Out Privacy Considerations Surrounding UBI Products 2Health News:TU-Automotive: Office of The Privacy Commissioner of Canada To Set Out Privacy Considerations Surrounding UBI Products 3Health News:NLN Commission for Nursing Education Accreditation (NLN CNEA) Announces Inaugural Commissioners 2Health News:NLN Commission for Nursing Education Accreditation (NLN CNEA) Announces Inaugural Commissioners 3Health News:Blue Cross and Blue Shield of Minnesota Reports 2014 Results 2Health News:Blue Cross and Blue Shield of Minnesota Reports 2014 Results 3Health News:GrassrootsHealth Launches CME Courses about Vitamin D 2Health News:GrassrootsHealth Launches CME Courses about Vitamin D 3Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 2Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 3Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 4
... Study finds treatment well-tolerated, kept tumors stable for ... News) -- A combination therapy of gemcitabine, capecitabine ... pancreatic cancer, according to a multi-center study led ... Buffalo, N.Y. , The study of 50 patients ...
... Ltd. today,announced the closing of an US$8.6 million ... the unique Angioslide eXtra(TM) angioplasty,balloon catheter that provides ... with embolic protection. The device has,received European CE ... clearance is,expected by end of 2008. The financing ...
... Data Presented at the 44th American Society for Clinical Oncology (ASCO) ... ... Pharma, Inc.,(Nasdaq: IDMI ) today announced the presentation of an analysis ... addition of L-MTP-PE to chemotherapy improved overall,survival with a 25% reduction in ...
... Representing US$204 Billion in Combined Sales Joined Private, ... Personal Care & Health Products, HONG KONG, ... sales of US$204 billion met 45 Greater China ... at Private Sourcing Events,( http://www.PrivateSourcingEvents.com ) for gifts ...
... the key to identifying high-risk behaviors among adolescents. ... are the leading causes of adolescent morbidity and mortality; ... these behavioral concerns. That paradox of care is the ... issue of Pediatrics, which found adolescents who participated in ...
... channel hosted exclusively by doctors, available 24/7 to listeners ... nationwide, ... ... and reports on general health and, wellness, plastic surgery, sexual health, child psychiatry, ...
Cached Medicine News:Health News:Angioslide Closes US$8.6million Series C Financing 2Health News:IDM Pharma Announces Data Supporting Improved Overall Survival Advantage in Newly Diagnosed Patients with Metastatic Osteosarcoma Treated with Mifamurtide (L-MTP-PE) 2Health News:IDM Pharma Announces Data Supporting Improved Overall Survival Advantage in Newly Diagnosed Patients with Metastatic Osteosarcoma Treated with Mifamurtide (L-MTP-PE) 3Health News:IDM Pharma Announces Data Supporting Improved Overall Survival Advantage in Newly Diagnosed Patients with Metastatic Osteosarcoma Treated with Mifamurtide (L-MTP-PE) 4Health News:IDM Pharma Announces Data Supporting Improved Overall Survival Advantage in Newly Diagnosed Patients with Metastatic Osteosarcoma Treated with Mifamurtide (L-MTP-PE) 5Health News:Meetings with Pre-Screened Verified China Suppliers Help 14 Top Buyers, Including Brookstone and Staples, Save Time and Cut Sourcing Costs 2Health News:Meetings with Pre-Screened Verified China Suppliers Help 14 Top Buyers, Including Brookstone and Staples, Save Time and Cut Sourcing Costs 3Health News:Meetings with Pre-Screened Verified China Suppliers Help 14 Top Buyers, Including Brookstone and Staples, Save Time and Cut Sourcing Costs 4Health News:Waiting room gadget may prove to be a life-saver 2Health News:SIRIUS Satellite Radio & NYU Langone Medical Center Launch 'Doctor Radio' Channel 2Health News:SIRIUS Satellite Radio & NYU Langone Medical Center Launch 'Doctor Radio' Channel 3Health News:SIRIUS Satellite Radio & NYU Langone Medical Center Launch 'Doctor Radio' Channel 4Health News:SIRIUS Satellite Radio & NYU Langone Medical Center Launch 'Doctor Radio' Channel 5Health News:SIRIUS Satellite Radio & NYU Langone Medical Center Launch 'Doctor Radio' Channel 6Health News:SIRIUS Satellite Radio & NYU Langone Medical Center Launch 'Doctor Radio' Channel 7Health News:SIRIUS Satellite Radio & NYU Langone Medical Center Launch 'Doctor Radio' Channel 8
... XCEL Suture Anchor is a 3.0mm single ... Acid (PLLA). The anchor barb catches on ... inserter until it "breaks" free. The small ... it also frequently used in rotator cuff ...
... an absorbable co-polymer synthesized from all-natural ... glycolic acid. Unlike the homopolymers in ... acid (PLLA) or 100% poly-glycolic acid ... (without crystallinity), meaning that its degradation ...
Sutureless Harpoon Tip...
... Ogden™ Sterile Anchor is a nonabsorbable repair ... using sutures. The device is implanted into ... is used to reattach damaged soft tissue. ... ELI) alloy which conforms to ASTM (F136-92). ...
Medicine Products: